Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches
Portfolio Pulse from Vandana Singh
Medtronic reported Q1 2025 earnings with revenue and EPS beating expectations. The company raised its annual guidance slightly, driven by growth in new product launches. Key segments like Cardiac Ablation Solutions and Neuromodulation showed strong performance.
August 20, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic's Q1 2025 earnings exceeded expectations with revenue of $7.92 billion and adjusted EPS of $1.23. The company raised its annual guidance slightly, indicating confidence in sustained growth from new product launches.
Medtronic's earnings beat and raised guidance suggest positive investor sentiment. The company's growth in key segments and new product launches indicate strong future performance, likely boosting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100